NovaBridge Biosciences (NBP) Shares Outstanding (Weighted Average) (2017 - 2025)

NovaBridge Biosciences (NBP) has 9 years of Shares Outstanding (Weighted Average) data on file, last reported at $220.3 million in Q4 2025.

• Quarterly Shares Outstanding (Weighted Average) rose 183549010.0% year-over-year to $220.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $220.3 million (up 183549010.0% YoY) and the FY2025 annual result came in at $220.3 million, up 183549010.0% from the prior year.
• Shares Outstanding (Weighted Average) rose to $220.3 million in Q4 2025 per NBP's latest filing, from $80.0 in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $220.3 million in Q4 2025 and bottomed at $20.0 in Q1 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $210.0 (2024), against an average of $52.7 million.
• The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) plunged 100.0%; it then surged 183549010.0% in 2025.
• Tracing NBP's Shares Outstanding (Weighted Average) over 5 years: stood at $27.3 million in 2021, then retreated by 2.35% to $26.7 million in 2022, then declined by 0.37% to $26.6 million in 2023, then plunged by 100.0% to $120.0 in 2024, then surged by 183549010.0% to $220.3 million in 2025.
• Per Business Quant, the three latest NBP Shares Outstanding (Weighted Average) figures stand at $220.3 million (Q4 2025), $80.0 (Q3 2025), and $50.0 (Q2 2025).

Peer Comparison